Al-Hammadi Development and Investment Company, a newly listed company, reported 2014’s net profit of SAR 129 million, a 16 percent increase compared to the last year.
A net profit of SAR 33.7 million was reported for Q4-2014 compared to SAR 25.4 million for Q3.
| Item | 2013 | 2014 | Change |
|---|---|---|---|
| Revenues | 434.08 | 481.96 | 11.0 % |
| Gross Income | 185.16 | 209.11 | 12.9 % |
| Operating Income | 112.10 | 130.95 | 16.8 % |
| Net Income | 111.50 | 128.95 | 15.6 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.70 | 0.81 | 15.6 % |
The Company attributed the increase of 2014’s net profit compared to the same period last year to the growth of revenue income driven by the growth of the number patients as well as improving the operating efficiency.
| Item | Q4 2013 | Q4 2014 | Change |
|---|---|---|---|
| Revenues | 124.13 | 129.43 | 4.3 % |
| Gross Income | 55.17 | 55.99 | 1.5 % |
| Operating Income | 34.34 | 34.52 | 0.5 % |
| Net Income | 33.29 | 33.71 | 1.2 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.21 | 0.21 | 1.2 % |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2014 | 122.04 | 16.4 % | 54.71 | 15.6 % | 34.23 | 14.7 % | 0.21 |
| Q2 2014 | 121.66 | 11.8 % | 53.68 | 17.1 % | 35.60 | 18.4 % | 0.22 |
| Q3 2014 | 108.83 | 13.1 % | 44.74 | 21.5 % | 25.42 | 38.7 % | 0.16 |
| Q4 2014 | 129.43 | 4.3 % | 55.99 | 1.5 % | 33.71 | 1.2 % | 0.21 |
| 2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 128.95 | 15.6 % | 0.81 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
| Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
| Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
| Q4 2014 | 43.39 % | 30.09 % | 26.75 % |
| 2014 | 43.39 % | 30.07 % | 26.75 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2014 | 160.00 | 0.72 | 0.69 | 3.87 |
| Q2 2014 | 160.00 | 0.76 | 0.76 | 7.88 |
| Q3 2014 | 160.00 | 0.80 | 0.80 | 8.04 |
| Q4 2014 | 160.00 | 0.81 | 0.81 | 8.25 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2014 | - | - | - |
| Q2 2014 | - | - | - |
| Q3 2014 | 51.42 | 51.42 | 5.14 |
| Q4 2014 | 48.92 | 48.92 | 4.78 |
2014
| Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
|---|
| Current | |
| Market Cap (M Riyal) | 7,512.00 |
| Enterprise Value (EV) (M) | 7,510.11 |
| Shares Outstanding ((M)) | 160.00 |
| EPS ( Riyal) (TTM) | 1.79 |
| Book Value (BV) ( Riyal) | 11.58 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 26.88 |
| P/E (TTM) | 26.27 |
| Price/book | 4.05 |
| Return on Average Assets (%) (TTM) | 11.1 |
| Return on Average Equity (%) (TTM) | 15.9 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}